• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据临床局限性前列腺癌活检阳性核心的百分比,前列腺外疾病的概率。

Probability of extraprostatic disease according to the percentage of positive biopsy cores in clinically localized prostate cancer.

作者信息

Valette Thiago N, Antunes Alberto A, Leite Katia Moreira, Srougi Miguel

机构信息

Division of Urology, University of São Paulo Medical School, São Paulo, Brazil.

出版信息

Int Braz J Urol. 2015 May-Jun;41(3):449-54. doi: 10.1590/S1677-5538.IBJU.2014.0223.

DOI:10.1590/S1677-5538.IBJU.2014.0223
PMID:26200538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4752137/
Abstract

OBJECTIVE

Prediction of extraprostatic disease in clinically localized prostate cancer is relevant for treatment planning of the disease. The purpose of this study was to explore the usefulness of the percentage of positive biopsy cores to predict the chance of extraprostatic cancer.

MATERIALS AND METHODS

We evaluated 1787 patients with localized prostate cancer submitted to radical prostatectomy. The percentage of positive cores in prostate biopsy was correlated with the pathologic outcome of the surgical specimen. In the final analysis, a correlation was made between categorical ranges of positive cores (10% intervals) and the risk of extraprostatic extension and/or bladder neck invasion, seminal vesicles involvement or metastasis to iliac lymph nodes. Student's t test was used for statistical analysis.

RESULTS

For each 10% of positive cores we observed a progressive higher prevalence of extraprostatic disease. The risk of cancer beyond the prostate capsule for <10% positive biopsy cores was 7.4% and it increased to 76.2% at the category 90-100% positive cores. In patients with Gleason grade 4 or 5, the risk of extraprostatic cancer prostate was higher than in those without any component 4 or 5.

CONCLUSION

The percentage of positive cores in prostate biopsy can predict the risk of cancer outside the prostate. Our study shows that the percentage of positive prostate biopsy fragments helps predict the chance of extraprostatic cancer and may have a relevant role in the patient's management.

摘要

目的

预测临床局限性前列腺癌的前列腺外疾病对于该疾病的治疗规划具有重要意义。本研究的目的是探讨阳性活检核心百分比预测前列腺外癌发生几率的实用性。

材料与方法

我们评估了1787例接受根治性前列腺切除术的局限性前列腺癌患者。前列腺活检中阳性核心的百分比与手术标本的病理结果相关。在最终分析中,对阳性核心的分类范围(以10%为间隔)与前列腺外扩展和/或膀胱颈侵犯、精囊受累或髂淋巴结转移的风险进行了相关性分析。采用Student's t检验进行统计学分析。

结果

每增加10%的阳性核心,我们观察到前列腺外疾病的患病率逐渐升高。活检阳性核心<10%时,前列腺包膜外癌的风险为7.4%,而在阳性核心为90%-100%的类别中,该风险增加到76.2%。在Gleason分级为4或5级的患者中,前列腺外癌的风险高于无任何4级或5级成分的患者。

结论

前列腺活检中阳性核心的百分比可预测前列腺外癌的风险。我们的研究表明,前列腺活检阳性碎片的百分比有助于预测前列腺外癌的发生几率,并且可能在患者管理中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01b/4752137/15689c0b67b7/1677-5538-ibju-41-3-0449-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01b/4752137/2e2d513d2dc2/1677-5538-ibju-41-3-0449-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01b/4752137/261cc062110c/1677-5538-ibju-41-3-0449-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01b/4752137/15689c0b67b7/1677-5538-ibju-41-3-0449-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01b/4752137/2e2d513d2dc2/1677-5538-ibju-41-3-0449-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01b/4752137/261cc062110c/1677-5538-ibju-41-3-0449-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01b/4752137/15689c0b67b7/1677-5538-ibju-41-3-0449-gf03.jpg

相似文献

1
Probability of extraprostatic disease according to the percentage of positive biopsy cores in clinically localized prostate cancer.根据临床局限性前列腺癌活检阳性核心的百分比,前列腺外疾病的概率。
Int Braz J Urol. 2015 May-Jun;41(3):449-54. doi: 10.1590/S1677-5538.IBJU.2014.0223.
2
The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.活检累及范围作为低危前列腺癌前列腺外侵犯和手术切缘状态的独立预测因素:对治疗选择的影响
J Urol. 2000 Dec;164(6):1982-6.
3
[Use of biopsy results to predict capsular perforation and seminal vesicle invasion in prostate cancer].[利用活检结果预测前列腺癌的包膜穿孔和精囊侵犯]
Beijing Da Xue Xue Bao Yi Xue Ban. 2003 Dec 18;35(6):581-5.
4
[Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy].[根治性前列腺切除术标本的解剖病理学分期与术前六分区活检中癌灶数量的相关性]
Actas Urol Esp. 2003 Jun;27(6):428-37. doi: 10.1016/s0210-4806(03)72949-0.
5
Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.术前前列腺活检诊断的伴有前列腺外侵犯的根治性前列腺切除术的临床、病理和肿瘤学发现。
J Urol. 2019 May;201(5):937-942. doi: 10.1016/j.juro.2018.10.023.
6
Prostate cancer polar localization on core biopsy predicts pathologic stage.前列腺癌在穿刺活检组织中的极性定位可预测病理分期。
Can J Urol. 2016 Dec;23(6):8551-8556.
7
[Extraprostatic disease prediction in patients with carcinoma of the prostate: role of PSA, prostatic biopsy fragments percentage and Gleason score].[前列腺癌患者的前列腺外疾病预测:前列腺特异性抗原、前列腺活检碎片百分比及 Gleason 评分的作用]
Rev Assoc Med Bras (1992). 2003 Jul-Sep;49(3):250-4. doi: 10.1590/s0104-42302003000300026. Epub 2003 Nov 5.
8
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.前列腺穿刺活检标本中癌阳性核心的百分比强烈预测根治性前列腺切除术中的肿瘤分期和体积。
J Urol. 2000 Jan;163(1):174-8.
9
A new nomogram to predict pathologic outcome following radical prostatectomy.一种预测根治性前列腺切除术后病理结果的新列线图。
Int Braz J Urol. 2006 Mar-Apr;32(2):155-64. doi: 10.1590/s1677-55382006000200005.
10
The total percentage of biopsy cores with cancer improves the prediction of pathological stage after radical prostatectomy.含有癌症的活检组织芯的总百分比可改善根治性前列腺切除术后病理分期的预测。
BJU Int. 2004 Oct;94(6):812-5. doi: 10.1111/j.1464-410X.2004.05038.x.

引用本文的文献

1
Open radical cystectomy: still the gold standard for muscle invasive bladder cancer.开放性根治性膀胱切除术:仍是肌层浸润性膀胱癌的金标准。
World J Urol. 2016 Jan;34(1):33-9. doi: 10.1007/s00345-015-1729-7. Epub 2015 Nov 19.

本文引用的文献

1
Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial.个体化评估斯堪的纳维亚前列腺癌群组随机试验中根治性前列腺切除术的获益。
Eur Urol. 2012 Aug;62(2):204-9. doi: 10.1016/j.eururo.2012.04.024. Epub 2012 Apr 19.
2
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
3
Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy.
在接受根治性前列腺切除术和广泛盆腔淋巴结清扫术的低危前列腺癌男性中,阳性活检的百分比可预测淋巴结受累情况。
BJU Int. 2011 Jan;107(2):220-5. doi: 10.1111/j.1464-410X.2010.09485.x.
4
Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer.前列腺癌淋巴结阳性患者行根治性前列腺切除术的生存获益。
Eur Urol. 2010 May;57(5):754-61. doi: 10.1016/j.eururo.2009.12.034. Epub 2010 Jan 20.
5
Optimal biopsy strategies for the diagnosis and staging of prostate cancer.用于前列腺癌诊断和分期的最佳活检策略。
Curr Opin Urol. 2009 May;19(3):232-7. doi: 10.1097/mou.0b013e328329a33e.
6
The role of extended prostate biopsy on prostate cancer detection rate: a study performed on the bench.扩大前列腺活检对前列腺癌检出率的作用:一项在实验台上进行的研究。
Int Braz J Urol. 2008 Sep-Oct;34(5):563-70; discussion 570-1. doi: 10.1590/s1677-55382008000500004.
7
Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.局限性前列腺癌根治性前列腺切除术与观察等待治疗的比较:斯堪的纳维亚前列腺癌研究组-4随机试验
J Natl Cancer Inst. 2008 Aug 20;100(16):1144-54. doi: 10.1093/jnci/djn255. Epub 2008 Aug 11.
8
Preoperative determination of prostate cancer tumor volume: analysis through biopsy fragments.前列腺癌肿瘤体积的术前测定:通过活检碎片进行分析
Int Braz J Urol. 2007 Jul-Aug;33(4):477-83; discussion 484-5. doi: 10.1590/s1677-55382007000400004.
9
The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy.在接受根治性前列腺切除术治疗的前列腺癌患者中,阳性活检核心的百分比作为疾病复发的预测指标。
BJU Int. 2005 Dec;96(9):1258-63. doi: 10.1111/j.1464-410X.2005.05823.x.
10
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.2005年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议。
Am J Surg Pathol. 2005 Sep;29(9):1228-42. doi: 10.1097/01.pas.0000173646.99337.b1.